Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks

The aim of the present study was to predict sustained virological response (SVR) to telaprevir with pegylated interferon (PEG-IFN) and ribavirin using viral response within 2 weeks after therapy initiation. Thirty-six patients with genotype 1 hepatitis C virus (HCV) and high viral load were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamai, Hideyuki, Shimizu, Ryo, Shingaki, Naoki, Mori, Yoshiyuki, Maeshima, Shuya, Nuta, Junya, Maeda, Yoshimasa, Moribata, Kosaku, Muraki, Yosuke, Deguchi, Hisanobu, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195394/
https://www.ncbi.nlm.nih.gov/pubmed/25328696
http://dx.doi.org/10.1155/2014/748935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195394/
https://www.ncbi.nlm.nih.gov/pubmed/25328696
http://dx.doi.org/10.1155/2014/748935

Ejemplares similares